English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
About ICMLF
Scientists supported by the John Goldman Fund: Uzma Zaidi
Dr Uzma Zaidi
(Karachi, Pakistan)
‘I thank iCMLf for providing me the opportunity to participate in the 18th John Goldman Conference. I got a chance to listen to international experts, to see what approaches they are following and how they are managing their patients. This meeting has greatly enhanced my knowledge on CML and given me so many new ideas to better help my patients in home town, both from the diagnostic and the management point of view’.
(Dr Zaidi, Pakistan)
Uzma Zaidi was supported by the iCMLf Goldman Fund to attend the John Goldman Conference on CML in Houston in 2016. She also undertook a 4-week clinical preceptorship at the MD Anderson Cancer Center in Houston directly after her attendance at the meeting.
‘The main issue in Pakistan is to get access to regular monitoring for my patients.
I am hoping to learn some diagnostic techniques during the preceptorship and to improve my skills and knowledge in terms of diagnosis and biology of CML. This will help me to find solutions for my patients’.
(Dr Zaidi in advance of her preceptorship)
Qian Jiang
Professor Qian JIANG, M.D.
Professor of International Medicine
Peking University People’s Hospital
Peking University Institute of Hematology
China
Medical education
- 1984-1990: M.D. Peking University Health Science Center
Clinical history
- 2017 - present: Chief Physician and Professor of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
- 2010 - 2017: Chief Physician and Associate Professor of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
- 2004 - 2010: Associate Chief Physician of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
- 1996 - 2004: Attending Doctor of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
- 1990 - 1996: Resident Physician of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
Research interests
- Clinical research of CML, MPN, AML, ALL, and CLL
Corporate Sponsors
The iCMLf Corporate sponsors
We are incredibly grateful for the support of the following organisations.
The work of the iCMLf is life changing for the people and communities reached. Thank you for supporting our mission to improve outcomes for CML patients around the world.
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
About the ICMLF
What is the iCMLf?
The iCMLf is a Foundation established by a group of hematologists with a strong interest in CML. Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales but our charter is global.
What are our aims and priorities?
The aims of the International CML Foundation (iCMLf) are to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML. There are numerous activities that could come within this broad charter but the initial focus is to meet the needs in CML that are not already being met by other groups, particularly those needs that are best met by a global organization.
What are our guiding principles?
- A focus on chronic myeloid leukemia and related disorders
- A truly independent not-for-profit foundation
- Collaboration with, but independence from, the pharmaceutical industry
- A global foundation with broad representation from all geographic regions
- Priorities and policies determined by hematologists and scientists involved in CML research and patient care
- Close consultation and cooperation with CML patient groups
- Active collaborations with key national and regional leukemia groups
How is the iCMLf governed and financed?
The iCMLf has
The iCMLf was co-sponsor of the International Meeting on CML with the European School of Hematology held in Bordeaux, September 11-13 2009, and will provide scientific leadership for future annual meetings (eg in Washington DC in September 2010)
Donate in John's memory
Donate in John's memory
A special thank you to those who have already donated to the John Goldman fund. It's thanks to your contribution that the John Goldman fund comes to life supporting young physicians from the emerging regions.
To donate to the iCMLf John Goldman fund click here
Scientists supported by the John Goldman Fund: Adeagbo Babatunde
Dr Adeagbo Babatunde, PhD
(Ile-Ife, Nigeria)
'It was an honour for me to present my data at this well-known conference on CML and to discuss the results with the international CML community. It was also a great chance for me to network with people from around the world and a great experience for me to listen to some of the most renowned leaders in the field of CML during the scientific sessions at the meeting.'
(Dr Babatunde, Nigeria)
Dr Babatunde was supported by the John Goldman Fund in 2015 to attend the John Goldman Conference on CML in Estoril. He presented his poster on ‘Pharmacokinetics on imatinib in Nigerians’ with CML during the interactive poster walks on the biology of CML.
